Join
Live feed
·
PRReleasevia Quantisnow
Instil Bio Inc. logo

Instil Bio Announces ImmuneOnco's Presentation of '2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)

ByQuantisnow·Wall Street's wire, on your screen.
TIL· Instil Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TIL (Instil Bio Inc.) and more on Quantisnow.